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Abstract
Introduction: The risk of tuberculosis (TB) in healthcare workers (HCWs) is related to its incidence in the general
population, and increased by the specific risk as a professional group. The prevalence of latent tuberculosis
infection (LTBI) in HCWs in Portugal using the tuberculin skin test (TST) and the interferon-g release assays (IGRA)
was analyzed over a five-year period.
Methods: A screening programme for LTBI in HCWs was conducted, with clinical evaluations, TST, IGRA, and chest
radiography. Putative risk factors for LTBI were assessed by a standardised questionnaire.
Results: Between September 2005 and June 2009, 5,414 HCWs were screened. The prevalence of LTBI was 55.2%
and 25.9% using a TST ≥ 10 mm or an IGRA test result (QuantiFERON-TB Gold In-Tube) INF-g ≥0.35 IU/mL as a
criterion for LTBI, respectively. In 53 HCWs active TB was diagnosed. The number of HCWs with newly detected
active TB decreased from 19 in the first year to 6 in 2008. Risk assessment was poorly related to TST diameter.
However, physicians (1.7%) and nurses (1.0%) had the highest rates of active TB.
Conclusions: LTBI and TB burden among HCWs in Portugal is high. The screening of these professionals to identify
HCWs with LTBI is essential in order to offer preventive chemotherapy to those with a high risk of future
progression to disease. Systematic screening had a positive impact on the rate of active TB in HCWs either by early
case detection or by increasing the awareness of HCWs and therefore the precautions taken by them.
Introduction
With the advent of antibiotics, many infectious diseases
such as tuberculosis (TB) seemed well under control [1].
This feeling of security led to an absence of investment
in implementing preventive measures and of training
and education for healthcare workers (HCWs) on the
risk of nosocomial infections and occupational diseases
[2]. The emergence of groups with epidemic TB infec-
tion, i.e. HIV/AIDS-patients, further aggravated the
situation [3].
In HCWs, the risk of TB infection is increased by
exposure to patients with infectious disease, insufficient
use of protective equipment such as respirators, and
working conditions, particularly in inadequately venti-
lated areas and when conducting techniques which
involve exposure to contaminated aerosols [3,4]. Given
this higher risk of contracting the disease by exposure
to M. tuberculosis in the workplace, in Portugal it is
considered an occupational disease [5]. The incidence of
TB in HCWs is related to the incidence in the general
population in that geographical area. Added to this is
the specific risk as a professional group, which depends
on the type of health unit, workgroup, and efficiency in
the implementation of infection control measures [6-9].
According to official records, the average rate of TB
reported in the general population in Portugal is 29.4/
100,000, which means that, despite the reduction
observed in recent years, it still has the highest inci-
dence in the EU excluding the countries of the 2004
enlargement [10]. Despite the mandatory notification of
active TB, there are no official records in Portugal of
the number of affected HCWs [11].
Early diagnosis and effective treatment of patients,
early recognition of possible contacts, the adoption of
protective measures and the effective screening for cases
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of latent tuberculosis infection (LTBI) are all necessary
for controlling the risk of TB in HCWs [9,12,13]. The
diagnosis of recent cases of LTBI (conversion) is parti-
cularly important since the lifetime risk of progression
to active disease ranges from 10 to 20% [12,14]. Accord-
ing to several studies, the treatment of LTBI reduces the
risk of developing active TB by more than 50% [15-17],
and is therefore one of the main objectives of a screen-
ing programme.
Until a few years ago, contacts were screened for con-
versions using the tuberculin skin test (TST) [18]. In
recent years, advances in molecular biology have led to
the development of new in-vitro tests that measure the
levels of interferon-g released by sensitized T lympho-
cytes after stimulation with antigens of M. tuberculosis.
These interferon-g release assays (IGRA) do not present
cross-reaction with Bacillus Calmet-Guérin (BCG), nor
with the majority of nontuberculous mycobacteria [19].
Several HCW studies using IGRA have been performed
so far comparing TST to IGRA [20-25]. While systema-
tic screening of HCWs for TB started in 2005 at the
S. João Hospital in Porto, Portugal, IGRA testing was
introduced to the screening process in 2007. The
subgroup in which TST and IGRA were performed
simultaneously is described in previous papers [22,23].
In this paper we describe the results of the screening
programme for the whole group that was screened
between 2005 and 2009. Special emphasis is placed on
workplace risk factors that might account for LTBI or
active TB in HCWs.
Methods
The risk of M. tuberculosis infection was assessed in
5,524 HCWs working or training in our hospital
between September 2005 and June 2009 (Figure 1).
According to the latest CDC guidelines (2005) and
based on the number of beds and patients diagnosed
with TB each year (average of 258 patients, and 17.2
HCWs per TB patient ratio), the hospital is classified as
a “medium risk” institution [9]. This screening was done
on a regular annual basis, whenever new staff were
employed, following occasional requests from sympto-
matic workers, or in cases of contact with infectious
patients or materials. The risk of transmission of TB
was classified as low, moderate and high, according to
the CDC [9].
This screening programme consisted of: 1) a standar-
dized interview covering gender, age, workplace, expo-
sure situation, TB history and TB-related respiratory
symptoms (cough, productive cough, haemoptysis, thor-
acalgia) as well as constitutional symptoms (fatigue,
weight loss, fever and night sweat), 2) chest radiography
(CXR) if TST or IGRA were positive or if symptomatic,
3) TST with 0.1 mL of 2 units of purified tuberculin
(PPD) RT 23 SSI, unless contraindication (previous
tuberculin reaction ≥15 mm, previous diagnosis of TB
with appropriate treatment, severe viral infection or
immunisation with vaccine with live virus less than 1
month ago, large extensive burns or eczema), and 4)
since April 2007 in-vitro enzyme immunoassay (ELISA)
test based on the quantification of interferon-g, Quanti-
FERON-TB Gold In-Tube (IGRA). This test was carried
out simultaneously with the TST [26]. A TST ≥ 10 mm
was considered as positive, in accordance with Portu-
guese guidelines [13]. IGRA tests were carried out on
the basis of the manufacture’s manual and considered
positive when ≥0.35 IU/mL. Undetermined IGRA results
were repeated once. If screening was performed as a
result of unprotected contact with infectious patients or
materials, TST and IGRA were performed eight weeks
after contact and CXR was performed 3 months and 12
months after contact.
Active TB was defined as infection with M. tuberculo-
sis, with or without symptoms and/or clinical signs, typi-
cal CXR and confirmed microbiologically. LTBI was
defined as infection with M. tuberculosis, without
any clinical manifestation, and was diagnosed if TST
≥ 10 mm or IGRA > 0.35 IU/mL after exclusion of
active TB regardless of CXR results due to the low sen-
sitivity and specificity of CXR for the diagnosis of LTBI.
The prevalence of LTBI when taking up employment
(first week of employment) was compared with follow-
up examinations.
Only in a subgroup were IGRA and TST performed
simultaneously. This is because IGRA testing was intro-
duced two years after the start of the systematic screen-
ing. The probability of a positive IGRA based on TST
results was calculated for this subgroup. These probabil-
ities were multiplied by the number of HCWs in the
whole study group who had the same TST results. Add-
ing up these products gave the number of HCWs that
can reasonably be expected to be IGRA-positive in the
whole group if they had all been tested with IGRA. This
allowed the proportion of IGRA-positive HCWs in the
whole study group to be estimated.
Statistical analysis was performed using a two-tailed
chi-square test to compare proportions of positive tests
(TST and IGRA) and StudentÂ´s t-test, and a simple
analysis of variance (one way ANOVA) to compare
means and standard deviations between groups. A
p-value < 0.05 was considered statistically significant.
Analysis was carried out with SPSS, Version 14.
The evaluation was carried out according to the objec-
tives of the Commission for the Prevention and Control
of Tuberculosis of Hospital S. João, no additional data
was collected, and the analysis was carried out anon-
ymously. For these reasons it was not necessary to
request approval by the Ethics Committee.
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Results
The study comprises 5,524 HCWs working or training
between September 2005 and June 2009 in our Hospital.
TST results are available for 5,209 HCWs (Figure 1).
Due to active TB in their medical history, TST was not
performed in 234 (4.3%) HCWs. Of these, 33 did not
know the year of diagnosis, 88 reported that it had
occurred before working as HCW and 113 afterwards.
Based on clinical evaluation and CXR, none of these 234
HCWs had active TB at the time of screening.
32.9% of the HCWs had a TST ≥ 15 mm and 55.2%
(32.9%+22.3%) had a TST ≥ 10 mm (Table 1). BCG vac-
cination did not increase the probability of a large TST
diameter, with 63.2% of those with a TST < 5 mm com-
pared to 53.9% of those with a TST ≥ 15 mm having a
record of BCG vaccination or a vaccination scar. Those
with a TST ≥ 15 mm were older and employed for
longer time as HCWs than those with a smaller TST
diameter (p-value for both trends 0.001). Surprisingly,
those with workplaces or tasks assumed to be of low
risk most often showed a TST ≥ 15 mm (37% versus
31% for moderate and 33.8% for high risk). On the
other hand, they were less likely to have a TST ≤ 5 mm
(25.7% versus 34.7% for moderate and 31.7% for high
risk) (p-value 0.001). Again surprisingly, physicians were
less likely to have a TST ≥ 15 (25.1% versus 38.4%
among operational assistants) and more likely to have a
TST ≤ 5 mm (41.4% versus 22.6% among administrative
assistants, Table 2) (p-value 0.013).
Since 2005, 53 cases of active TB have been diagnosed
(Table 3), of which 19 occurred in 2005, the year the
systematic screening started. This was also the year with
the highest rate of active TB in the screening popula-
tion. The number of HCWs with active TB in the
Figure 1 Study population.
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population declined in the following years: 13 in 2006,
14 in 2007, 6 in 2008 and 1 HCW with active TB in the
first six month of 2009. HCWs considered to be at low
risk of TB exposure were less likely to have active TB
(0.5%) than those with moderate (1.3%) or high risk of
exposure (0.9%) (p-value 0.023). Contrary to the prob-
ability of a TST ≥ 10 mm, which was second lowest for
physicians among all of the HCWs screened, the prob-
ability of active TB was highest for physicians (1.7%) fol-
lowed by nurses (1.0%) (p-value 0.034).
IGRA was performed in 1,686 HCWs (Table 4). For
13 (<1%) HCWs IGRA was indeterminate. This
remained the case for 4 of these after the second deter-
mination. The subgroup with determinate IGRAs (n =
1,682) was comparable to the whole group (n = 5209) in
which TST was performed with respect to gender
(female 72% versus 72%), age (36 years Std 10.8 versus
38 years Std 11); and duration of employment in health-
care (11 years Std 10.5 years versus 12 years Std 11, no
table).
Out of 1,682 HCWs with a determined IGRA, 558
(33.2%) were positive. Probability of a positive IGRA
increased with the diameter of the TST. However, even
with a diameter of ≥15 mm only 49.2% of these HCWs
had positive IGRA results (Table 4). Applying the prob-
abilities of a positive IGRA for the different diameter
category of the TST to all HCWs tested with TST pro-
duces a positive IGRA rate of 25.9% (calculated from
Table 1 and Table 3).
Comparing the prevalence of LTBI found during the
first week of employment (n = 1144) and follow-up
examinations (n = 4062), a significantly higher preva-
lence was found in the latter, with 17.7% versus 29.0%
using IGRA and 38.0% versus 60.1% using TST as a cri-
terion for determining LTBI (no table, p-values for both
IGRA and TST < 0.001).
Discussion
Our descriptive data show that the TB burden among
Portuguese HCWs is high with 53 out of 5,209 (1%)
being diagnosed with active TB in the five-year period
from 2005 to 2009. Accordingly, the prevalence of LTBI
Table 2 Profession by TST
TST in mm
<5 ≥5 - <10 ≥10 - <15 ≥15
N (%) N (%) N (%) N (%)
Operational Assistent 234 (35.2) 108
(16.3)
166 (25.0) 256 (38.6)
Administrative
Assistent
76 (22.6) 47 (14.0) 84 (25.0) 129 (38.4)
Nurse 533 (28.8) 202
(10.9)
419 (22.7) 695 (37.6)
Physician 528 (41.4) 162
(12.7)
264 (20.7) 320 (25.1)
Technician 163 (35.4) 73 (15.8) 99 (21.5) 126 (27.3)









Table 3 Distribution of active TB cases since 2005 (n =
53) according to risk and profession
TST pos Active TB Total
Risk N % N % N
Low 521 62.3 4 0.5 836
Moderate 1360 52.6 33 1.3 2588
High 997 55.9 16 0.9 1785
Profession
Operational Assistent 422 63.6 6 0.9 664
Administrative Assistent 213 63.4 0 – 336
Nurse 1114 60.3 18 1.0 1849
Physician 584 45.8 21 1.7 1274
Technician 225 40.1 4 0.7 561
Others 320 61.0 3 0.6 525
All 2878 55.3 53 1.0 5209
Table 4 IGRA and TST in subgroup simultaneously tested
[23]
IGRA All
TST in mm pos % neg % N Col%
<5 10 5.3 177 94.7 187 11.1
≥5 - <10 23 12.9 155 87.1 178 10.6
≥10 - <15 168 28.4 423 71.6 591 35.1
≥15 357 49.2 369 50.8 726 43.2
All 558 33.2 1124 66.8 1682 100.0







N (%) N (%) N (%) N (%)




714 (61.3) 924 (53.9)
Age ± SD (years) 35 ± 10.7 37 ±
11.9
39 ± 12 41 ±10.7
Duration of exposure ±
SD
9 ± 9.6 12 ±
11.3
13 ± 11.6 16 ± 10.8
Low Risk (row%) 215 (25.7) 100
(12.0)
212 (25.4) 309 (37.0)
Moderate risk 897 (34.7) 331
(12.8)
558 (21.6) 802 (31.0)
High risk 566 (31.7) 222
(12.4)
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is high. However, estimates of LTBI prevalence vary to a
great extent depending on whether prevalence is
assessed with TST or IGRA (55% versus 26%).
Similar variations are found for HCWs in other coun-
tries, too. For instance, in a study involving 171 nurses
from London the prevalence of LTBI was 16.2% by TST
and 7.6% with the IGRA [27]. The relationship between
TST and IGRA in this study is similar to the one we
report, despite the much higher prevalence of LTBI in
our hospital, which probably reflects differences between
the two countries regarding the prevalence of LTBI in
the general population [7,10,28]. In other studies, the
prevalence of LTBI in HCWs has ranged from 22 to
41% with TST (≥10 mm) and of 10 to 40% with IGRA
tests [20,27,29,30]. In a review conducted by Menzies et
al in 2007 [7], the prevalence of LTBI in higher-income
countries ranges from 11% to 30% (with TST), while in
low-income countries it is estimated between 60% and
80% [21]. In Portugal there are no similar studies for
comparison. If we accept the prevalence found in our
hospital as representative of the country, Portugal would
have a prevalence of LTBI in HCWs that is higher than
in countries with high incomes but lower than in low-
income countries. In our previous publication, preva-
lence of LTBI was 33.2% when assessed by IGRA [23].
However, this figure seems to overestimate LTBI preva-
lence in the total screening population because IGRA
was more often performed in HCWs with a higher TST.
Prevalence of LTBI is more likely to be in the range of
25% for the whole screening population.
The incidence of M. tuberculosis infection in HCWs is
related to the incidence in the general population in
that geographical area. Added to this is the increased
risk as a professional group and work conditions
[6-9,31]. In a study by de Vries G et al [32], 67 HCWs
with TB were evaluated and it was determined that in
42% of these cases the infection had been acquired in
the hospital, 28% in the community and 30% abroad.
Another concept for risk assessment examines the
relationship between the number of admissions for TB
with the number of HCWs. In hospitals with over 200
admissions per year, or a ratio between the number of
HCWs and admissions for TB of less than 1/10, the
annual risk of infection (ARTI) in HCWs seems to be
between 1 and 10% [2]. In the hospital where this study
took place, the average number of admissions for TB as
the primary diagnosis was 258 per year, giving a ratio of
17.2 HCWs (physicians and nurses) per TB admission
and thus ranking it as a moderate-risk hospital [9].
The control of TB as a nosocomial infection requires,
above all, the adoption of a “non-reactive” attitude, as it
is known that most cases of TB transmission in hospitals
occur in places where collective and individual measures
of protection were not properly implemented (due to low
probability of occurrence) [32]. Therefore, the rapid iden-
tification of patients with known or suspected active TB,
the rapid implementation of airborne precautions and
the use of a surgical mask or N95 respirator by the HCW
are necessary measures for active protection. If TB
patients are suspected of having MDR/XDR-TB, this
might even warrant the use of more effective respirators
for the HCWs. Given the low effectiveness of the BCG
vaccination [33,34], the strategy for preventing TB should
be based on the identification and treatment of LTBI as a
way of reducing the number of infected individuals, and
the risk of progression to active TB [18].
In our study, the distribution of TB cases was not uni-
form over the years in question, with a maximum of 19
in 2005 (equivalent to 351/100.000), which is almost
eight times higher than the incidence among the general
population in the same geographical area (10). Since the
implementation of this screening programme, there has
been a significant reduction in TB cases. In 2008 only 6
cases of TB were diagnosed and in the first half of 2009
only 1 case. No new measures of infection control were
implemented that might explain this effect. We believe
that HCWsÂ´ awareness of protective measures
increased. They were therefore adhering to the rules
more closely. Detection bias might also have a certain
influence. At the start of the systematic screening there
may have been some cases detected early or cases that
would shortly have been detected anyway. In later years
this leveled off towards early case detection.
Both TST and IGRA tests have limitations in the diag-
nosis of LTBI. The main problems with TST depend on
technical limitations, difficulty in interpreting the results
and the existence of a significant number of false positives
[13,35,36]. On the other hand, IGRA tests, despite being
more specific and having at least identical sensitivity to
TST [20,37-39], present difficulties in interpreting results
near the cut-off between positive/negative and also have
higher unit costs [24,40]. The absence of a gold standard
to correctly identify the sensitivity and specificity of each
test poses a challenge [41]. The inability of both tests to
distinguish between infection and immunological memory
is a further shortcoming. A positive test indicates an
immune response to stimulation by mycobacterial anti-
gens, and not necessarily the existence of live M. tubercu-
losis in the human host. The percentage of individuals
who are truly infected with M. tuberculosis after a TST or
IGRA conversion is actually unknown. Therefore the term
“latent infection” should be understood as the persistence
of immune response and not necessarily as a potential risk
for progression to disease [42].
To circumvent the booster effect problem, it is sug-
gested to repeat the TST with a one-week interval (two
steps), particularly in populations with high rates of
BCG vaccination [13,43-45]. In this study, the difficult
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interpretation of this effect, the decrease in compliance
by repetition of TST and the simultaneous use of IGRA
tests were reasons for not performing the two-step TST
systematically.
Risk assessment was not confirmed by distribution of
TST diameter in our study, e.g. the highest proportion
of TST ≥ 15 mm was observed in HCWs assumed to be
at low risk of TB exposure. Two effects might explain
this seemingly contradictory observation. First, risk clas-
sifications are based on a certain stability of profes-
sionals in the workplace [9], which generally is not
observed. Second the habits, training and awareness
necessary for taking personal protection measures, and
socioeconomic characteristics of each group can con-
found the association between positive TST and risk
assessment. Analysing the rate of active TB rather than
positive TST gave a better association between perceived
risk and actual TB burden, e.g. physician and nurses had
the highest rates of active TB and those with low risk
had the lowest rate of active TB.
Concerning limitations of the study, selection bias is
of major concern. There is a certain selection bias
because HCWs with recent contact with TB patients
and HCWs with high TST diameters in their medical
history are more likely to have screening performed.
This explains why IGRA positivity is higher in the sub-
group with simultaneous TST and IGRA testing than in
the whole group. Therefore the rate of positive IGRAs
estimated for the whole group is more likely to be the
proportion of positive IGRA results (25.9%) to be
expected for HCWs in comparable hospitals in Portugal.
Conclusions
The TB burden in Portuguese HCWs working in com-
parable hospitals is high. The screening of these profes-
sionals is essential for an early diagnosis of active
disease. It is also essential to identify cases with higher
risk of future progression to disease as these profes-
sionals are most likely to benefit from preventive
chemotherapy.
Since the implementation of this screening pro-
gramme, the incidence of TB has decreased, which sup-
ports the importance of TB screening as a disease
control measure, both by identifying high-risk cases and
by alerting HCWs to this problem.
The authors declare that they do not have any direct
or indirect personal relationship, affiliation or associa-
tion with any party with whom they deal in their day to
day work that would give rise to any actual or perceived
conflict of interest.
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